These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1848329)

  • 21. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis.
    Wuthrich RP; Yui MA; Mazoujian G; Nabavi N; Glimcher LH; Kelley VE
    Am J Pathol; 1989 Jan; 134(1):45-51. PubMed ID: 2492404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine gene expression in the MRL/lpr model of lupus nephritis.
    Lemay S; Mao C; Singh AK
    Kidney Int; 1996 Jul; 50(1):85-93. PubMed ID: 8807576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    Nowling TK; Rodgers J; Thiyagarajan T; Wolf B; Bruner E; Sundararaj K; Molano I; Gilkeson G
    PLoS One; 2020; 15(3):e0230499. PubMed ID: 32187230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
    Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
    FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of short-term treatment with the prostaglandin E1 (PGE1) analog misoprostol on inflammatory mediator production in murine lupus nephritis.
    Fan PY; Ruiz P; Pisetsky DS; Spurney RF
    Clin Immunol Immunopathol; 1995 May; 75(2):125-30. PubMed ID: 7704969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
    Yang H; Xu A; Lv J; Liu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):821-5. PubMed ID: 22699062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK/STAT signaling controls the fate of CD8
    Zhou M; Guo C; Li X; Huang Y; Li M; Zhang T; Zhao S; Wang S; Zhang H; Yang N
    J Autoimmun; 2020 May; 109():102424. PubMed ID: 32085893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
    Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
    Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of BATF, a member of the activator protein-1 family, in renal tissues of MRL/lpr mice].
    Peng Y; Li Q; Wang M; Cao C; Lai K; Zeng K
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):816-9. PubMed ID: 26111677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis.
    Benz PS; Fan X; Wüthrich RP
    Kidney Int; 1996 Jul; 50(1):156-63. PubMed ID: 8807584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis.
    Wuthrich RP
    Kidney Int; 1992 Oct; 42(4):903-14. PubMed ID: 1280699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
    You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
    BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotrienes and other lipoxygenase products of arachidonic acid synthesized in the kidney.
    Ardaillou R; Baud L; Sraer J
    Am J Med; 1986 Aug; 81(2B):12-22. PubMed ID: 3019135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced hyaluronan synthesis in the MRL-Fas(lpr) kidney: role of cytokines.
    Feusi E; Sun L; Sibalic A; Beck-Schimmer B; Oertli B; Wüthrich RP
    Nephron; 1999 Sep; 83(1):66-73. PubMed ID: 10461038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4.
    Dahinden CA; Clancy RM; Gross M; Chiller JM; Hugli TE
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6632-6. PubMed ID: 2995976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.